FindTrial
Sign In

A study to evaluate the efficacy of saraswatha ghrita in the children with ADHD

A comparative clinical study to evaluate the efficacy of Saraswatha Ghritha and Kushmanda Ghritha in Attention Deficit Hyperactivity Disorder (ADHD) - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112835
Enrollment
40
Registered
2026-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type

Interventions

None listed

Sponsors

Dr Sowparnika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling diagnostic criteria of ADHD according to DSM 5 Mild to moderate symptoms,irrespective of gender religion socioeconomic status

Exclusion criteria

Exclusion criteria: Systemic disorder Presence of other psychiatric illness subject under modern conventional therapy

Design outcomes

Primary

MeasureTime frame
to evaluate the changes in the symptoms of ADHD by administering saraswatha ghritha and kushmanda ghritha. in the following symptoms 1 Inattention 2 Hyperactivity 3 Impulsivity And to compare the efficacy of saraswatha ghrita and kushmanda ghritaTimepoint: On the 0th,15th,31st, 45th day—

Secondary

MeasureTime frame
Measuring the changes in children by using conners rating scaleTimepoint: On the 0th,15th,31st,45th day—

Countries

India

Contacts

Public ContactDr Vinitha Dsouza

Alvas Ayurveda medical college

vinithadsouza25@gmail.com9964156473

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026